Members of the Sackler family, the billionaire owners of Purdue Pharma, reached an agreement to pay up to $6 billion to resolve lawsuits alleging the OxyContin maker helped fuel the opioid epidemic.

David Sackler (Raymond's grandson) and Dr. Kathe Sackler (Mortimer's daughter), both former Purdue Board members, recently went public to defend the family's actions, and its name, testifying ...

The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 billion settlement.

Forbes Valuation. Forbes values the Sackler family’s net worth at $5.2 billion as of February, based on an estimated $11.2 billion in liquid assets minus the $6 billion they were set to pay in ...

Members of the Sackler family—who no longer have any affiliation with Purdue Pharma—have previously claimed they “acted lawfully in all respects,” though they’ve acknowledged OxyContin ...

Purdue Pharma announced its settlement with all 55 attorneys general on Monday after longstanding allegations.

Some members of Congress and attorneys general for about half the states oppose that plan, which includes a requirement for Sackler family members to pay at least $3 billion in addition to giving ...

Those groups are now joining with Purdue and Sackler family members to defend the plan from appeals from an office of U.S. Department of Justice, eight states, the District of Columbia, some ...

Purdue Pharma and Sackler family members who own the company have reached a $7.4 billion settlement with all 50 states and U.S. territories over the company's improper marketing of opioids.

State AGs have reached a new opioid settlement worth $7.4 billion with Purdue Pharma and its owners. The settlement does not give Sackler family members immunity from future opioid lawsuits.

The Sackler family members disputed the $11 billion figure on Monday, saying that half of the money they took from the company was used for tax payments. Purdue, ...